BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 19298722)

  • 1. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
    Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
    Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.
    Nückel H; Rebmann V; Dürig J; Dührsen U; Grosse-Wilde H
    Blood; 2005 Feb; 105(4):1694-8. PubMed ID: 15466928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
    Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HLA-G gene expression in B-lymphocytes from chronic lymphocytic leukemia patients.
    Rezvany MR; Kazemi A; Hajifathali A; Kaviani S; Mellstedt H
    Iran Biomed J; 2007 Apr; 11(2):125-129. PubMed ID: 18051955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Dmoszyńska A; Bojarska-Junak A; Schmitt M; Roliński J
    Folia Histochem Cytobiol; 2008; 46(4):457-60. PubMed ID: 19141398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.
    Attia MA; Nosair NA; Gawally A; Elnagar G; Elshafey EM
    Acta Haematol; 2014; 132(1):53-8. PubMed ID: 24557341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
    Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers in chronic lymphocytic leukaemia.
    Hamblin TJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
    el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
    Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients.
    Gogia A; Sharma A; Raina V; Kumar L; Gupta R; Kumar R
    Indian J Cancer; 2013; 50(4):333-6. PubMed ID: 24369212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.